Skip to content
Inciteful Med

Symptoms & Disease Progression: What to Expect

Last updated:

Myotonic dystrophy is a multisystemic disease that causes progressive muscle weakness, delayed muscle relaxation, and hidden symptoms like severe daytime sleepiness, apathy, and digestive issues. Type 1 and Type 2 present differently and progress based on the age symptoms begin.

Key Takeaways

  • • Myotonic dystrophy is a multisystemic condition affecting the muscles, heart, brain, eyes, and digestive tract.
  • • Type 1 (DM1) disease progression is closely linked to the age of onset, with the classic adult form starting with weakness in the hands and feet.
  • • Type 2 (DM2) typically causes weakness closer to the body, such as in the hips and shoulders, and often involves significant muscle pain.
  • • Hidden symptoms like excessive daytime sleepiness, apathy, and executive dysfunction are biological features of the disease, not personal flaws.
  • • Gastrointestinal problems, including trouble swallowing and chronic constipation, are common and can be severe in both types of myotonic dystrophy.

Myotonic Dystrophy is much more than a muscle disease; it is a multisystemic condition that can affect the heart, brain, eyes, and digestive tract [1]. Because it affects so many parts of the body, symptoms can sometimes feel disconnected or “hidden” [2].

Understanding DM1: Progression by Age of Onset

In Type 1 (DM1), the age at which symptoms first appear often predicts how the disease will progress. This is closely linked to the size of the genetic “repeat” expansion [3].

Congenital DM1 (Present at Birth)

The most severe form occurs when symptoms are present from birth.

  • Early Signs: Infants often experience hypotonia (severe muscle floppiness), difficulty breathing, and trouble feeding [4].
  • Long-term: Many children will experience intellectual disabilities, developmental delays, and significant social challenges as they grow [5][6].

Childhood-onset DM1

Symptoms often appear between ages 1 and 10 and may not look like a muscle disease at first.

  • Cognitive & Behavioral: Parents often first notice learning disabilities, ADHD-like symptoms, or features of the autism spectrum [5][7].
  • Physical Signs: Excessive daytime sleepiness and gastrointestinal (GI) issues like stomach pain or constipation are very common but often overlooked [8][9].

Adult-onset DM1 (The “Classic” Form)

This typically appears in the 20s, 30s, or 40s.

  • Muscle Weakness: Weakness usually starts in the distal muscles—those furthest from the center of the body, like the hands (grip strength) and feet (foot drop) [10].
  • Myotonia: The hallmark “sticky grip” where muscles take a long time to relax [11].
  • Systemic Issues: Early-onset cataracts (often called “Christmas tree” cataracts) and heart rhythm problems are common [12][13].

Understanding DM2: A Different Pattern

Type 2 (DM2) is generally milder and has a different pattern of muscle involvement.

  • Proximal Weakness: Unlike DM1, weakness in DM2 starts in the proximal muscles—those closest to the body, like the hips, thighs, and shoulders. This makes tasks like climbing stairs or getting out of a chair difficult [10].
  • Muscle Pain (Myalgia): Significant muscle pain is a major feature of DM2, often more prominent than in DM1 [14].
  • Metabolic Risks: Patients with DM2 have a higher risk of developing diabetes and insulin resistance earlier in life [15][16].

The “Hidden” Symptoms

Many patients find that the non-muscle symptoms are the most challenging to manage because they are not always visible.

Excessive Daytime Sleepiness (EDS) & Apathy

  • The Cause: This sleepiness is usually “central,” meaning it comes from changes in the brain’s sleep-wake signals, not just from poor sleep [17].
  • Apathy: Many patients experience a lack of motivation or “get-up-and-go” [18]. It is important to know that this is a biological symptom of the disease, not a personality flaw or simple laziness [19]. This validation is critical for explaining your experience to friends, family, and employers.

Gastrointestinal (GI) Issues

The muscles that move food through your body can also be affected, leading to dysmotility [9]. Both upper and lower digestive issues—including trouble swallowing (dysphagia) and chronic constipation—are extremely common and can be severe in both DM1 and DM2 [9][20]. Shared symptoms also include frequent bloating, diarrhea, or abdominal pain [9].

Cognitive and Executive Function

Both types can affect the brain, but in profound ways. In adult-onset DM1, profound executive dysfunction (having trouble with complex tasks like planning, organizing, or multi-tasking) and apathy are hallmark, debilitating features of the disease [18][21]. DM2 also frequently presents with executive dysfunction and memory challenges [22][23].

To cope with these cognitive changes, patients often benefit from working with an occupational therapist, setting phone alarms, using habit-tracking apps, and writing down daily routines to turn overwhelming tasks into manageable steps [18].

Frequently Asked Questions

What are the first signs of adult-onset myotonic dystrophy?
In adult-onset Type 1 (DM1), early signs typically include weakness in the hands and feet, along with a "sticky grip" where muscles take a long time to relax. Early-onset cataracts and heart rhythm problems are also common early indicators.
How is Type 2 myotonic dystrophy different from Type 1?
Type 2 (DM2) generally causes weakness in the muscles closest to the body, like the hips and shoulders, making tasks like climbing stairs difficult. It also features more significant muscle pain and carries a higher risk of developing early insulin resistance compared to Type 1.
Why do I feel so unmotivated and apathetic with myotonic dystrophy?
Many patients experience apathy and a lack of motivation due to biological changes in the central nervous system. It is important to know that this is a recognized medical symptom of the disease, not a personality flaw or simple laziness.
Can myotonic dystrophy cause stomach and digestive problems?
Yes, gastrointestinal issues are very common because the condition affects the muscles that move food through your body. This can lead to frequent bloating, severe constipation, abdominal pain, and trouble swallowing.
Why am I so tired during the day even if I sleep well at night?
Excessive daytime sleepiness is usually a central nervous system issue, meaning it stems from changes in the brain's sleep-wake signals rather than just poor nighttime sleep. This profound fatigue is a core feature of the disease that should be discussed with your doctor.

Questions for Your Doctor

  • • Which 'hidden' symptoms, like sleepiness or digestive issues, should we be monitoring right now?
  • • Given my subtype, what specific heart and lung tests do I need to have on a regular basis?
  • • Is the profound fatigue and lack of motivation I am feeling a result of central nervous system changes, and what treatments are available for it?
  • • How can we screen for cognitive or executive function changes as the disease progresses?

Questions for You

  • • How often do I feel sleepy during the day, even after a full night's rest?
  • • Have I noticed any changes in my personality or motivation, such as feeling more 'apathetic' than usual?
  • • Am I experiencing more frequent stomach issues like bloating, constipation, or trouble swallowing?
  • • Are my muscles most painful or weak in my hands and feet, or closer to my body in my hips and shoulders?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Myotonic Dystrophies: Targeting Therapies for Multisystem Disease.

    LoRusso S, Weiner B, Arnold WD

    Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2018; (15(4)):872-884 doi:10.1007/s13311-018-00679-z.

    PMID: 30341596
  2. 2

    [Adult myotonic dystrophy type 1: an update].

    Rosado-Bartolomé A, Gutiérrez-Gutiérrez G, Prieto-Matos J

    Semergen 2020; (46(5)):355-362 doi:10.1016/j.semerg.2020.01.002.

    PMID: 32646725
  3. 3

    Myotonic dystrophy type 1 testing, 2024 revision: A technical standard of the American College of Medical Genetics and Genomics (ACMG).

    Seifert BA, Reddi HV, Kang BE, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2024; (26(8)):101145 doi:10.1016/j.gim.2024.101145.

    PMID: 38836869
  4. 4

    Clinical and genetic characteristics of childhood-onset myotonic dystrophy.

    Stokes M, Varughese N, Iannaccone S, Castro D

    Muscle & nerve 2019; (60(6)):732-738 doi:10.1002/mus.26716.

    PMID: 31520483
  5. 5

    MECP2-related pathways are dysregulated in a cortical organoid model of myotonic dystrophy.

    Morelli KH, Jin W, Shathe S, et al.

    Science translational medicine 2022; (14(651)):eabn2375 doi:10.1126/scitranslmed.abn2375.

    PMID: 35767654
  6. 6

    Hard ways towards adulthood: the transition phase in young people with myotonic dystrophy.

    Baldanzi S, Ricci G, Simoncini C, et al.

    Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology 2016; (35(3)):145-149.

    PMID: 28484315
  7. 7

    PREPUBERTAL GYNECOMASTIA: A RARE MANIFESTATION OF MYOTONIC DYSTROPHY TYPE 1.

    Miranda PSF, Pereira EPMN, Barreto JSCB, et al.

    Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo 2020; (38()):e2018294 doi:10.1590/1984-0462/2020/38/2018294.

    PMID: 32074227
  8. 8

    Assessment of self-reported and objective daytime sleepiness in adult-onset myotonic dystrophy type 1.

    Sansone VA, Proserpio P, Mauro L, et al.

    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2021; (17(12)):2383-2391 doi:10.5664/jcsm.9438.

    PMID: 34170223
  9. 9

    High frequency of gastrointestinal manifestations in myotonic dystrophy type 1 and type 2.

    Hilbert JE, Barohn RJ, Clemens PR, et al.

    Neurology 2017; (89(13)):1348-1354 doi:10.1212/WNL.0000000000004420.

    PMID: 28855409
  10. 10

    Myotonic dystrophy type 2: the 2020 update.

    Meola G

    Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology 2020; (39(4)):222-234 doi:10.36185/2532-1900-026.

    PMID: 33458578
  11. 11

    Quantitative myotonia assessment with a commercially available dynamometer in myotonic dystrophy types 1 and 2.

    Horáková M, Horák T, Parmová O, et al.

    Muscle & nerve 2019; (59(4)):431-435 doi:10.1002/mus.26401.

    PMID: 30575988
  12. 12

    Investigating phenotypic variability patterns in myotonic dystrophy type 2 in a neuromuscular referral center retrospective cohort.

    Picher-Martel V, Locascio JJ, Chuang K, et al.

    Neuromuscular disorders : NMD 2025; (47()):105255 doi:10.1016/j.nmd.2024.105255.

    PMID: 39708548
  13. 13

    Sudden Death Caused by Bilateral Diaphragmatic Eventration in Myotonic Dystrophy Type 1.

    Wu S, Prahlow JA

    The American journal of forensic medicine and pathology 2025; (46(4)):330-336 doi:10.1097/PAF.0000000000001073.

    PMID: 40928346
  14. 14

    Multidimensional aspects of pain in myotonic dystrophies.

    Peric M, Peric S, Rapajic N, et al.

    Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology 2015; (34(2-3)):126-32.

    PMID: 27199540
  15. 15

    Milestones of progression in myotonic dystrophy type 1 and type 2.

    Hamel JI, McDermott MP, Hilbert JE, et al.

    Muscle & nerve 2022; (66(4)):508-512 doi:10.1002/mus.27674.

    PMID: 35778789
  16. 16

    Therapeutic advances in type 1 myotonic dystrophy complicated with type 2 diabetes mellitus.

    Luo L, Zhu C, Yang S, et al.

    Frontiers in neurology 2025; (16()):1640563 doi:10.3389/fneur.2025.1640563.

    PMID: 41018201
  17. 17

    Excessive daytime sleepiness in myotonic dystrophy: a narrative review.

    Hoxhaj D, Pascazio A, Maestri M, et al.

    Frontiers in neurology 2024; (15()):1389949 doi:10.3389/fneur.2024.1389949.

    PMID: 39011358
  18. 18

    Cognitive Deficits, Apathy, and Hypersomnolence Represent the Core Brain Symptoms of Adult-Onset Myotonic Dystrophy Type 1.

    Miller JN, Kruger A, Moser DJ, et al.

    Frontiers in neurology 2021; (12()):700796 doi:10.3389/fneur.2021.700796.

    PMID: 34276551
  19. 19

    Fluid Biomarkers of Central Nervous System (CNS) Involvement in Myotonic Dystrophy Type 1 (DM1).

    Rossi S, Silvestri G

    International journal of molecular sciences 2023; (24(3)) doi:10.3390/ijms24032204.

    PMID: 36768526
  20. 20

    Impact of gastrointestinal and urological symptoms in children with myotonic dystrophy type 1.

    Maagdenberg SJM, Klinkenberg S, Sophie van den Berg J, et al.

    Neuromuscular disorders : NMD 2024; (35()):1-7 doi:10.1016/j.nmd.2023.12.011.

    PMID: 38184901
  21. 21

    Patient Input to Inform the Development of Central Nervous System Outcome Measures in Myotonic Dystrophy.

    White M

    Therapeutic innovation & regulatory science 2020; (54(5)):1010-1017 doi:10.1007/s43441-020-00117-3.

    PMID: 31970692
  22. 22

    Executive Dysfunction, Social Cognition Impairment, and Gray Matter Pathology in Myotonic Dystrophy Type 2: A Pilot Study.

    Theodosiou T, Christidi F, Xirou S, et al.

    Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology 2022; (35(3)):204-211 doi:10.1097/WNN.0000000000000314.

    PMID: 35867610
  23. 23

    Neuropsychological Assessment Should Always be Considered in Myotonic Dystrophy Type 2.

    Theodosiou T, Christidi F, Xirou S, et al.

    Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology 2021; (34(1)):1-10 doi:10.1097/WNN.0000000000000263.

    PMID: 33652465

This page is for informational purposes only and does not replace professional medical advice. Always consult your healthcare provider or neurologist about your specific myotonic dystrophy symptoms and disease progression.

Stay up to date

Get notified when new research about Myotonic dystrophy is published.

No spam. Unsubscribe anytime.